PRTA

Prothena Corporation PLC

Price

$9.66

return (12m)

15.14%

p/e

-11.01

p/bv

1.69

DIVIDEND YIELD

0.00%

PRTA price

Prothena Corporation

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PRTA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.18%

3 months

9.90%

1 year

15.14%

2 years

-54.52%

5 years

-86.47%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PRTA

Valuation

P/E

-11.01

Sector -4.23

Industry -4.23

P/BV

1.69

Sector 2.11

Industry 2.11

P/Revenue (PSR)

8.88

Sector 2.05

Industry 2.05

EV/EBITDA

-10.60

Sector -546.75

Industry -546.75

EV/EBIT

-10.48

Sector -37.85

Industry -37.85

P/EBITDA

-8.20

Sector -51.33

Industry -51.33

P/EBIT

-8.09

Sector -39.56

Industry -39.56

P/Total Assets

1.60

Sector 1.25

Industry 1.25

P/Net Current Assets

1.75

Sector -5.36

Industry -5.36

P/Working Capital

1.73

Sector -1.24

Industry -1.24

EPS

-0.85

Sector -1.92

Industry -1.92

BVPS

5.52

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

100.00%

Sector 39.10%

Industry 39.10%

EBITDA Margin

-1,830.69%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

-1,850.50%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

-100.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

-80.67%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-15.33%

Sector -60.49%

Industry -60.49%

ROA

-14.54%

Sector -63.06%

Industry -63.06%

ROIC

-373.53%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

25.04

Sector 2.90

Industry 2.90

Net Debt / EBITDA

15.59

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

15.42

Sector -10.24

Industry -10.24

Net Debt / Equity

-1.00

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.95

Sector 0.43

Industry 0.43

Liabilities/Assets

0.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-22.93%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals PRTA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PRTA Prothena Corporation PLC	$9.66	16.81%	0.00%	-11.01	1.69	-15.33%	-80.67%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PRTA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Prothena Corporation

Prothena Corporation PLC

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2012

Time since IPO - 14 years

66

Employees

Prothena Corporation PLC (United States) is listed on the Nasdaq and has a market capitalization of $484.12 million, with shareholders equity totaling $286.89 million.

The company employs approximately 66 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Prothena Corporation PLC reported $54.53 million in revenue, generating net income of $-43.99 million.

Key financial metrics include a P/E ratio of -11.01, a price-to-book (P/B) ratio of 1.69, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PRTA.

Market cap

$484.12 million

Net worth

$286.89 million

$286,890,000.00

Assets

$302.58 million

$302,580,000.00

Total Shares Outstanding

52.00 million

52,000,000

Average Daily Trading Volume

$532.58 Thousand

$532,579.86

Sector

Health Care

Industry

Biotechnology

PRTA

PRTA revenue and profits

Financial Results PRTA

DRAG THE FRAME TO SEE MORE DATA

PRTA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Prothena Corporation (PRTA) today?

A cotação de Prothena Corporation (PRTA) hoje está em US$ 9.66, com uma variação de 15.14% em relação ao último ano. A cotação de Prothena Corporation (PRTA) iniciou o ano negociando na casa dos US$ 9.55 e hoje está em US$ 9.66. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Prothena Corporation (PRTA) e dados de ações do Ibovespa e mercados internacionais.

Quando Prothena Corporation (PRTA) paga dividendos?

Prothena Corporation (PRTA) não distribuiu dividendos no último ano.

Is Prothena Corporation (PRTA) a good investment?

Atualmente, Prothena Corporation (PRTA) está cotada a US$ 9.66, com um P/L de -11.01, representando um desvio de -1,165% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 15.14 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 15.14%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Prothena Corporation (PRTA) stock?

Investir em ações de Prothena Corporation (PRTA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Prothena Corporation (PRTA) yield today?

A rentabilidade de Prothena Corporation (PRTA) foi de 13.18% no último mês, 15.14% no último ano e -86.47% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Prothena Corporation (PRTA) hoje, o investimento total seria de US$ 966.00, com base na cotação atual de US$ 9.66.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,112.25
Em 5 anos: US$ 130.70
Em 10 anos: US$ 966.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PRTA

Prothena Corporation PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PRTA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PRTA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Prothena Corporation

Prothena Corporation PLC

United States

14 years

2012

66

PROFIT X PRICE PRTA

Financial Results PRTA

PRTA cash flow

Asset, Revenue and Profit Growth - PRTA

PRTA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions